Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia-Reference-Cited by-同舟云学术

Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia

Published:1989-06 Issue:6 Volume:38 Page:542-549
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Pappu Anuradha S.,Illingworth D.Roger,Bacon Sandra

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference50 articles.

1. Coronary disease in familial hypercholesterolemia;Jensen;Circulation,1967

2. Risks of ischemic heart disease in familial hyperlipoproteinemic states;Slack;Lancet,1969

3. Coronary artery disease in 116 kindered with familial type II hyperlipoproteinemia;Stone;Circulation,1974

4. Heterozygous familial hypercholesterolemia: Relationship between plasma lipids, lipoproteins, clinical manifestations and ischemic heart disease in men and women;Gagne;Atherosclerosis,1979

5. Familial hypercholesterolemia: Genetic, biochemical and pathological considerations;Brown;Adv Intern Med,1975

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome;Journal of Inherited Metabolic Disease;2012-03-06

2. Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome;Journal of Inherited Metabolic Disease;2007-11

3. Increased nonsterol isoprenoids, dolichol and ubiquinone, in the Smith-Lemli-Opitz syndrome: effects of dietary cholesterol;Journal of Lipid Research;2006-12

4. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia;Journal of Laboratory and Clinical Medicine;2003-04

5. The effects of lovastatin and simvastatin on the diurnal periodicity of plasma mevalonate concentrations in patients with heterozygous familial hypercholesterolemia;Atherosclerosis;2002-11